利尔化学(002258) - 2019 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2019 was ¥1,017,783,095.28, representing a 12.48% increase compared to ¥904,849,549.85 in the same period last year[10] - Net profit attributable to shareholders decreased by 37.51% to ¥72,245,409.40 from ¥115,606,905.86 year-on-year[10] - The basic earnings per share fell by 37.51% to ¥0.1378 from ¥0.2205 in the same period last year[10] - Net profit attributable to shareholders decreased by 37.51% to 7,224.54 million, mainly due to a reduction in total profit[26] - The company expects net profit for the first half of 2019 to decline by 20% to 50% compared to the same period last year[29] - The net profit range for the first half of 2019 is estimated to be between 130,323.7 million and 208,517.9 million[31] - Net profit for the current period was ¥91,890,171.17, a decrease of 29.5% from ¥130,456,728.57 in the previous period[62] - Total comprehensive income attributable to the parent company was CNY 72,245,409.40, down from CNY 115,606,905.86 in the previous period, representing a decrease of approximately 37.5%[65] - Basic and diluted earnings per share decreased to CNY 0.1378 from CNY 0.2205, reflecting a decline of about 37.5%[65] - Operating profit decreased to CNY 73,222,647.84 from CNY 118,328,594.33, a decline of about 38.1%[66] - Net profit for the period was CNY 65,020,768.19, down from CNY 100,843,089.61, indicating a decrease of approximately 35.7%[66] Cash Flow - The net cash flow from operating activities surged by 655.96% to ¥162,662,002.48, compared to ¥21,517,270.63 in the previous year[10] - Cash inflow from operating activities totaled ¥651,993,744.97, up from ¥392,079,492.36 in the previous period, indicating a growth of approximately 66%[77] - Cash outflow from operating activities increased to ¥503,971,565.06 from ¥415,374,276.68, reflecting a rise of about 21%[77] - Cash flow from operating activities increased significantly to CNY 1,030,161,969.71 from CNY 723,891,106.18, representing a growth of approximately 42.4%[70] - Cash flow from investing activities showed a net outflow of CNY 197,216,549.32, improving from a net outflow of CNY 242,378,854.18 in the previous period[76] - Cash flow from financing activities generated a net inflow of CNY 273,140,355.18, down from CNY 527,202,881.43, a decrease of about 48.2%[76] - The ending cash and cash equivalents balance increased to CNY 812,396,362.88 from CNY 693,097,898.42, reflecting a growth of approximately 17.2%[76] - The net cash flow from operating activities was ¥148,022,179.91, a significant improvement compared to a net outflow of ¥-23,294,784.32 in the previous period, representing a turnaround of over 100%[77] Assets and Liabilities - Total assets increased by 7.72% to ¥7,080,156,390.88 from ¥6,572,840,788.84 at the end of the previous year[10] - Current assets increased to ¥3,004,104,858.87 as of March 31, 2019, up from ¥2,605,616,174.25 as of December 31, 2018, representing a growth of approximately 15.2%[40] - Total non-current assets reached ¥4,076,051,532.01, compared to ¥3,967,224,614.59, showing an increase of about 2.7%[43] - Total liabilities reached ¥3,423,392,170.62, compared to ¥2,887,076,145.34, indicating an increase of approximately 18.5%[46] - Current liabilities increased to ¥2,181,358,174.28 from ¥1,758,174,747.92, reflecting a rise of about 24.0%[46] - Total liabilities were reported at ¥2,887,076,145.34, indicating a stable financial position[88] - The total equity attributable to shareholders was ¥3,157,448,080.75, reflecting a solid equity base for the company[88] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 27,309[14] - The largest shareholder, Sichuan Jiuyuan Investment Holding Group Co., Ltd., held 27.36% of the shares, amounting to 143,484,136 shares[14] Research and Development - Research and development expenses surged by 128.81% to 7,263.14 million, reflecting increased investment in R&D[26] - Research and development expenses increased significantly to ¥72,631,361.03, compared to ¥31,743,328.57 in the previous period, reflecting a growth of 128.5%[59] - Research and development expenses surged to CNY 51,559,946.60 from CNY 17,624,928.95, an increase of about 192.5%[66] Other Financial Metrics - The company reported non-recurring gains and losses totaling ¥4,438,746.61 for the period[10] - Management expenses increased by 34.21% to 5,711.86 million due to the expansion of operational scale[26] - Other payables increased by 95.38% to 26,743.69 million, mainly due to undistributed dividends from 2018[26] - Tax expenses decreased by 35.97% to 1,553.72 million, primarily due to a reduction in total profit[26] - The company reported a significant increase in other income to ¥5,583,304.00 from ¥3,822,561.50, reflecting a growth of 46.1%[62] Audit and Reporting - The first quarter report was not audited[95]